NovaBay Pharmaceuticals Reports Preliminary Q1 FY24 Net Revenue For Its Eyecare And Wound Care Business Of $2.6M, Up 13% YoY
NovaBay Pharmicals报告称,其眼部护理和伤口护理业务的24财年第一季度初步净收入为260万美元,同比增长13%
NovaBay Pharmaceuticals Reports Preliminary Q1 FY24 Net Revenue For Its Eyecare And Wound Care Business Of $2.6M, Up 13% YoY
NovaBay Pharmicals报告称,其眼部护理和伤口护理业务的24财年第一季度初步净收入为260万美元,同比增长13%
使用浏览器的分享功能,分享给你的好友吧